Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β

Glycogen synthase kinase 3 (GSK3) plays important roles in Wnt and insulin signaling, cell fate determination, and Alzheimer‐like tau phosphorylation. We discovered an isoform of tau protein kinase I (TPKI)/GSK3β with a 13 amino acid insert in the catalytic domain owing to alternative splicing. The alternative transcripts were found in the brains of the mouse, rat and human, with highly conserved sequences. The variant protein, named TPKI2/GSK3β2, was abundant in the brain. Immunohistochemistry indicated differential distribution of the conventional and the new TPKI/GSK3β isoforms within young neurons. TPKI2/GSK3β2 showed decreased kinase activities towards two phosphorylation sites on tau compared with the conventional isoform. Immunohistochemistry indicated that TPKI2/GSK3β2 occurs predominantly in the neuronal soma, while TPKI1/GSK3β1 is found both in the soma and processes. These results indicate that the new splice isoform has a different function. Because the amino acid insert occurs in the domain implicated in interaction with a protein phosphatase in a homologous kinase cdk‐2, the alternative splicing can regulate multiprotein complex formation and function involving TPKI/GSK3β.

[1]  Yue Sun,et al.  Identification of alternative splicing variants of the β subunit of human Ca2+/calmodulin‐dependent protein kinase II with different activities , 2000, FEBS letters.

[2]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[3]  J. Woodgett,et al.  Modulation of the glycogen synthase kinase‐3 family by tyrosine phosphorylation. , 1993, The EMBO journal.

[4]  S. Wiemann,et al.  The protein kinase A catalytic subunit Cbeta2: molecular characterization and distribution of the splice variant. , 2000, The Biochemical journal.

[5]  G L Johnson,et al.  Organization and regulation of mitogen-activated protein kinase signaling pathways. , 1999, Current opinion in cell biology.

[6]  K. Imahori,et al.  Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites , 1995, Neuroscience Letters.

[7]  S. Wiemann,et al.  Isoform C beta 2, an unusual form of the bovine catalytic subunit of cAMP-dependent protein kinase. , 1991, The Journal of biological chemistry.

[8]  Robert V Farese,et al.  Regulation of Alternative Splicing of Protein Kinase Cβ by Insulin (*) , 1995, The Journal of Biological Chemistry.

[9]  Laurence H. Pearl,et al.  Crystal Structure of Glycogen Synthase Kinase 3β Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition , 2001, Cell.

[10]  P. Grabowski.  Splicing Regulation in Neurons: Tinkering with Cell-Specific Control , 1998, Cell.

[11]  P. Seeburg,et al.  Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  H. Singer,et al.  Novel Ca2+/Calmodulin-dependent Protein Kinase II γ-Subunit Variants Expressed in Vascular Smooth Muscle, Brain, and Cardiomyocytes* , 1997, The Journal of Biological Chemistry.

[13]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Marc W. Kirschner,et al.  Control of b-Catenin Stability : Reconstitution of the Cytoplasmic Steps of the Wnt Pathway in Xenopus Egg Extracts , 2000 .

[15]  Norinobu M. Watanabe,et al.  The Ste20 group kinases as regulators of MAP kinase cascades. , 2001, Trends in cell biology.

[16]  E. Matsubara,et al.  Aβ amyloidosis induces the initial stage of tau accumulation in APPSw mice , 2001, Neuroscience Letters.

[17]  U. Wagner,et al.  Tau phosphorylation in transgenic mice expressing glycogen synthase kinase‐3β transgenes , 1997, Neuroreport.

[18]  V. Lee,et al.  Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons* , 1997, The Journal of Biological Chemistry.

[19]  J. Bell,et al.  In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase , 1997, Molecular and cellular biology.

[20]  S. Ohmori,et al.  cDNA Cloning of an Alternative Splicing Variant of Protein Kinase C δ (PKC δIII), a New Truncated Form of PKCδ, in Rats , 2000 .

[21]  G. Blobe,et al.  Selective regulation of expression of protein kinase C beta isoenzymes occurs via alternative splicing. , 1993, The Journal of biological chemistry.

[22]  L. Johnson,et al.  Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. , 2001, Molecular cell.

[23]  P. Cohen,et al.  The role of protein phosphorylation in the hormonal control of enzyme activity. , 1985, European journal of biochemistry.

[24]  N. Perrimon,et al.  wingless signaling acts through zeste-white 3, the drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate , 1992, Cell.

[25]  Y. Nishizuka,et al.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.

[26]  K. Imahori,et al.  Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. , 1997, Journal of biochemistry.

[27]  M. Schroeder,et al.  Casein kinase I alpha and alpha L: alternative splicing-generated kinases exhibit different catalytic properties. , 1996, Biochemistry.

[28]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[29]  Y. Nishizuka,et al.  Expression and properties of two types of protein kinase C: alternative splicing from a single gene. , 1987, Science.

[30]  K. Imahori,et al.  Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .

[31]  M. Cobb,et al.  Isolation of MEK5 and Differential Expression of Alternatively Spliced Forms * , 1995, The Journal of Biological Chemistry.

[32]  K. Imahori,et al.  A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau. , 1988, Journal of biochemistry.

[33]  L. Swenson,et al.  Structure of GSK3β reveals a primed phosphorylation mechanism , 2001, Nature Structural Biology.

[34]  P. Cohen,et al.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. , 2001, Molecular Cell.

[35]  F. McCormick,et al.  Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.

[36]  S. Hellberg,et al.  crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor , 2004 .

[37]  D. Black.  Protein Diversity from Alternative Splicing A Challenge for Bioinformatics and Post-Genome Biology , 2000, Cell.

[38]  S. Fujita,et al.  Inhibition of Protein Phosphatase 2A Overrides Tau Protein Kinase I/Glycogen Synthase Kinase 3β and Cyclin-dependent Kinase 5 Inhibition and Results in Tau Hyperphosphorylation in the Hippocampus of Starved Mouse* , 2001, The Journal of Biological Chemistry.

[39]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[40]  W. Blackstock,et al.  Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry , 2000, Journal of neurochemistry.

[41]  J. Woodgett,et al.  PHF‐tau from Alzheimer's brain comprises four species on SDS‐PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase‐3β , 1994, FEBS letters.

[42]  K. Imahori,et al.  Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. , 1992, The Journal of biological chemistry.

[43]  R. Moon,et al.  Signal transduction through beta-catenin and specification of cell fate during embryogenesis. , 1996, Genes & development.

[44]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[45]  H. K. Sluss,et al.  Selective interaction of JNK protein kinase isoforms with transcription factors. , 1996, The EMBO journal.

[46]  A. Harwood,et al.  Regulation of GSK-3 A Cellular Multiprocessor , 2001, Cell.

[47]  E. Braak,et al.  Distribution, Levels, and Activity of Glycogen Synthase Kinase‐3 in the Alzheimer Disease Brain , 1997, Journal of neuropathology and experimental neurology.

[48]  篠崎 一雄,et al.  シロイヌナズナMAP kinase cascadesの解析 , 1996 .

[49]  H. Usui,et al.  GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with Axin , 2000, Oncogene.

[50]  P. Cohen,et al.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.

[51]  K. Imahori,et al.  Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments , 1992, Neuroscience Letters.

[52]  J. H. Schwartz,et al.  Two catalytic subunits of cAMP-dependent protein kinase generated by alternative RNA splicing are expressed in Aplysia neurons , 1988, Neuron.

[53]  K. Imahori,et al.  Localization and Developmental Changes of τ Protein Kinase I/Glycogen Synthase Kinase‐3β in Rat Brain , 1994 .

[54]  H. Schulman,et al.  Developmental and regional expression of multifunctional Ca2+/calmodulin-dependent protein kinase isoforms in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  M. Kirschner,et al.  Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. , 2000, Molecular cell.

[56]  P. Cohen,et al.  Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase. , 1981, European journal of biochemistry.

[57]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[58]  G. Drewes,et al.  Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau , 1992, FEBS letters.

[59]  D. Thomis,et al.  Mechanism of interferon action. cDNA structure and regulation of a novel splice-site variant of the catalytic subunit of human protein kinase A from interferon-treated human cells. , 1992, The Journal of biological chemistry.

[60]  H. Schulman,et al.  Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus , 1994, The Journal of cell biology.

[61]  R. Davis,et al.  Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. , 1998, Trends in biochemical sciences.

[62]  J. McGill,et al.  Alternative splice variant of gamma-calmodulin-dependent protein kinase II alters activation by calmodulin. , 2000, Archives of biochemistry and biophysics.

[63]  Y. Nishizuka,et al.  Two types of complementary DNAs of rat brain protein kinase C , 1986, FEBS letters.

[64]  M. Mercken,et al.  Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[65]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[66]  K. Imahori,et al.  Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II , 1996, Acta Neuropathologica.

[67]  K. Imahori,et al.  Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology , 1996, Brain Research.

[68]  J. Woodgett,et al.  Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.